Russian government to simplify launch of new drugs

The Russian government has prepared a bill simplifying the introduction of new drugs into the domestic pharmaceutical market, a spokesman of state press-service has said recently, reports The Pharma Letter’s local correspondent.

At present, before a new drug reaches the consumer, it must undergo a lot of various procedures and checks.

In the case of generics, the duration of laboratory and clinical studies of such drugs may take an average of a year and a half, while for original drugs this could be in the range of five to six years.